Yes, the pumpers have and always will be screaming buy the dips. Me? I am not a pumper, I have held my average of .08 through this entire summer when the pps dipped to .0301... Yeah I was there that day watching.
The thing about the pps valuation is that this is still a new public company. To a lot of PXYN strangers, that 400k profit looks more like a fluke than a steady trend upward. Once a profit is reoccurring and shows stability, big investors, shy investors, "on the fence" investors will jump in. So this fluke to them looks nothing like stability or the upward trend Due Diligence predicts.
For me, I am not worried at all. The legitimacy of this company is far superior to most of the OTC. Big pharmaceutical companies possess multiple pharmaceutical state licenses - just like this one. To acquire a pharmaceutical license from the state pharmaceutical board is no cake walk. And this company went through all the hassle and admin work to acquire 12 licenses through 12 different state pharmacy boards. There should be no doubt of this company's potential or legitimacy - they did not go through all that hassle on acquiring these licenses for nothing.
This stock is still brand new, and requires some patience for the rest of the world to buy in. A failed shell company scared a lot away, and for awhile the only crowd buying this was reverse merger players. They are making all the right moves. Time will truly tell what the future holds for PXYN - not pumpers and bashers. I could be considered a pumper because I show enthusiasm and I am sure others are just as enthusiastic. So GLTU and watch time unfold PXYN into what they could potentially be.
News 
Market Data 
Discover 
